Imcl
Rob, Fortune magazine must have been right on the dot. I read about the possibilities you cited above last week, but shrugged at them. Anyhow, Icahn is a man that I trust a lot. He is just cleaning house. I think a lot of the old insiders have become too complacent for his taste.
Also, Fortune mentioned that IMCL might lose part of their patent to sell Erbitux-- which will make it harder for the company to sell its products abroad. The article estimates a cut of 20% in company's revenue if the ruling comes against IMCL. I personally didn't think this part of the article had any credible evidence. So, evidence of losing a patent ruling at this time is unfound. If anything, they have a great chance of FDA approval to treat pancreatic and liver cancer with Erbitux.
Originally posted by Rob
View Post
Also, Fortune mentioned that IMCL might lose part of their patent to sell Erbitux-- which will make it harder for the company to sell its products abroad. The article estimates a cut of 20% in company's revenue if the ruling comes against IMCL. I personally didn't think this part of the article had any credible evidence. So, evidence of losing a patent ruling at this time is unfound. If anything, they have a great chance of FDA approval to treat pancreatic and liver cancer with Erbitux.
Comment